{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:39:20Z","timestamp":1790674760467,"version":"4.1.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple factors are involved in the process leading to melanocyte loss in vitiligo including environmental triggers, genetic polymorphisms, metabolic alterations, and autoimmunity. This review aims to highlight current knowledge on how danger signals released by stressed epidermal cells in a predisposed patient can trigger the innate immune system and initiate a cascade of events leading to an autoreactive immune response, ultimately contributing to melanocyte disappearance in vitiligo. We will explore the genetic data available, the specific role of damage-associated-molecular patterns, and pattern-recognition receptors, as well as the cellular players involved in the innate immune response. Finally, the relevance of therapeutic strategies targeting this pathway to improve this inflammatory and autoimmune condition is also discussed.<\/jats:p>","DOI":"10.3389\/fimmu.2021.613056","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T06:57:59Z","timestamp":1618383479000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective"],"prefix":"10.3389","volume":"12","author":[{"given":"Katia","family":"Boniface","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Seneschal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meri K.","family":"Tulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12803","article-title":"Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma","volume":"32","author":"Willemsen","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900027","article-title":"The Role of Memory CD8+ T Cells in Vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/pcmr.12848","article-title":"The genetic architecture of vitiligo","volume":"33","author":"Roberts","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jid.2019.06.131","article-title":"Pediatric to Adult Shift in Vitiligo Onset Suggests Altered Environmental Triggering","volume":"140","author":"Jin","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.06.004","article-title":"The Genetic Basis of Vitiligo","volume":"41","author":"Spritz","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu","year":"2012","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.624566","article-title":"Begum R. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis","volume":"11","author":"Jadeja","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15151","article-title":"Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo","volume":"176","author":"Kim","year":"2017","journal-title":"Br J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15538","article-title":"Oxidative stress and high-mobility group box 1 (HMGB1) protein release in vitiligo","volume":"176","author":"Becatti","year":"2017","journal-title":"Br J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13895","article-title":"HMGB1 deficiency reduces H2 O2 -induced oxidative damage in human melanocytes via the Nrf2 pathway","volume":"22","author":"Mou","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.jid.2019.03.1148","article-title":"Oxidative Stress-Induced HMGB1 Release from\u00a0Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in\u00a0Vitiligo","volume":"139","author":"Cui","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.268","article-title":"Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes","volume":"134","author":"Zhang","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12208","article-title":"Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress","volume":"27","author":"Mosenson","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12183","article-title":"A central role for inducible heat-shock protein 70 in autoimmune vitiligo","volume":"22","author":"Mosenson","year":"2013","journal-title":"Exp Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.45","article-title":"HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo","volume":"128","author":"Denman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"174ra28","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant HSP70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson","year":"2013","journal-title":"Sci Transl Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.06.186","article-title":"HSP70iQ435A-Encoding DNA Repigments Vitiligo Lesions in Sinclair Swine","volume":"138","author":"Henning","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.185704","article-title":"Heat Shock Protein-70 Expression in Vitiligo and its Relation to the Disease Activity","volume":"61","author":"Doss","year":"2016","journal-title":"Indian J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2015.00278","article-title":"Polymorphisms in Toll-like receptor genes are associated with vitiligo","volume":"6","author":"Traks","year":"2015","journal-title":"Front Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04514.x","article-title":"TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients","volume":"27","author":"Karaca","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.10.036","article-title":"Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo","volume":"145","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1222808110","article-title":"NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1\u03b2 processing via the NLRP1 inflammasome","volume":"110","author":"Levandowski","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-004-0620-6","article-title":"Reading the viral signature by Toll-like receptors and other pattern recognition receptors","volume":"83","author":"Mogensen","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"000181","DOI":"10.23880\/VIJ-16000181","article-title":"Viral causes of Vitiligo: A New Perspective for Vitiligo Pathogenesis","volume":"2","author":"Dwivedi","year":"2018","journal-title":"Virol Immunol J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41419-020-2665-z","article-title":"Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion","volume":"11","author":"Zhuang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/srep18761","article-title":"Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects","volume":"6","author":"Ganju","year":"2016","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jid.2019.08.435","article-title":"Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice","volume":"140","author":"Dellacecca","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.01.036","article-title":"Analysis of Matched Skin and Gut Microbiome of Vitiligo Patients Reveals Deep Skin Dysbiosis: Link With Mitochondrial and Immune Changes","author":"Bzioueche","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PloS One"},{"key":"B35","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03617.x","article-title":"Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease","volume":"35","author":"Serarslan","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2012007500152","article-title":"Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris","volume":"46","author":"Ma","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20186068","article-title":"Macrophage migration inhibitory factor as an incriminating agent in vitiligo","volume":"93","author":"Farag","year":"2018","journal-title":"Bras Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.149","article-title":"Type I IFNs at the interface between cutaneous immunity and epidermal remodeling","volume":"132","author":"Conrad","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15550","article-title":"Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis","volume":"177","author":"Jacquemin","year":"2017","journal-title":"Br J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133772","article-title":"Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo","volume":"5","author":"Boukhedouni","year":"2020","journal-title":"JCI Insight"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(86)70085-6","article-title":"Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study","volume":"14","author":"Halder","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02681.x","article-title":"Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study","volume":"22","author":"Basak","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(89)70069-4","article-title":"Circadian rhythm of natural killer cell activity in vitiligo","volume":"20","author":"Mozzanica","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0190-9622(92)70094-v","article-title":"Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo","volume":"26","author":"Mozzanica","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","article-title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","volume":"144","author":"Jimbow","year":"2001","journal-title":"Br J Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-13-18","article-title":"Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions","volume":"13","author":"Shi","year":"2012","journal-title":"BMC Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2002.02065.x","article-title":"Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes","volume":"15","author":"Lu","year":"2002","journal-title":"Pigment Cell Res"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le Poole","year":"1993","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2016.11.007","article-title":"Medical and Maintenance Treatments for Vitiligo","volume":"35","author":"Passeron","year":"2017","journal-title":"Dermatol Clin"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.07.108","article-title":"The effectiveness of topical calcineurin inhibitors compared with topical corticosteroids in the treatment of vitiligo: A systematic review and meta-analysis","volume":"82","author":"Chang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22027","article-title":"Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients","volume":"223","author":"Dell\u2019Anna","year":"2010","journal-title":"J Cell Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.328","article-title":"Activation of the unfolded protein response in vitiligo: the missing link","volume":"132","author":"Passeron","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-226779","article-title":"Basic evidence for epidermal H2O2\/ONOO(-)-mediated oxidation\/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS","volume":"27","author":"Schallreuter","year":"2013","journal-title":"FASEB J"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14792","article-title":"Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis","volume":"32","author":"Speeckaert","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"13663","DOI":"10.1038\/s41598-017-13961-5","article-title":"Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin","volume":"7","author":"Dell\u2019Anna","year":"2017","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.04.025","article-title":"MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo","volume":"137","author":"Sahoo","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz8631","article-title":"Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair","volume":"12","author":"Myles","year":"2020","journal-title":"Sci Transl Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus","volume":"129","author":"Furie","year":"2019","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5354","article-title":"Hydroxychloroquine protects melanocytes from autoantibody-induced injury by reducing the binding of antigen-antibody complexes","volume":"14","author":"Li","year":"2016","journal-title":"Mol Med Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12442","article-title":"Improvement of vitiligo in a patient with rheumatoid arthritis after hydroxychloroquine treatment","volume":"18","author":"Joo","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00441","article-title":"NKG2D: A Master Regulator of Immune Cell Responsiveness","volume":"9","author":"Wensveen","year":"2018","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3109\/08916934.2011.593599","article-title":"Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo","volume":"44","author":"Zloza","year":"2011","journal-title":"Autoimmunity"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.jid.2019.11.013","article-title":"NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo","volume":"140","author":"Jacquemin","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1735615","article-title":"Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis","author":"Phan","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"B72","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/1203475419833609","article-title":"The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature","volume":"23","author":"Relke","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial","volume":"396","author":"Rosmarin","year":"2020","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.613056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T02:21:46Z","timestamp":1698891706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.613056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2021.613056"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.613056","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"article-number":"613056"}}